Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines

Al B. Benson, Alan P. Venook, Tanios Bekaii-Saab, Emily Chan, Yi Jen Chen, Harry S. Cooper, Paul F. Engstrom, Peter C. Enzinger, Moon J. Fenton, Charles S. Fuchs, Jean L. Grem, Axel Grothey, Howard S. Hochster, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Lucille A. Leong, Edward Lin, Wells A. Messersmith, Mary F. MulcahyJames D. Murphy, Steven Nurkin, Eric Rohren, David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Kristina M. Gregory, Deborah Freedman-Cass

Research output: Contribution to journalArticlepeer-review

183 Scopus citations

Abstract

The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Rectal Cancer Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize major discussion points from the 2015 NCCN Rectal Cancer Panel meeting. Major discussion topics this year were perioperative therapy options and surveillance for patients with stage I through III disease.

Original languageEnglish
Pages (from-to)719-728
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume13
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Dive into the research topics of 'Rectal cancer, version 2.2015: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this